Justin Stebbing

Justin Stebbing

Department of Surgery and Cancer, Imperial College London

Affiliated withImperial College London

Research Area

Medicine

Biography

JoVE Journal Publications

ArticleTotal : 1
Year
Mammosphere Formation Assay from Human Breast Cancer Tissues and Cell Lines
Publication title
2015

Other Publications

Article
Year
Protein kinases as targets for cancer treatment.

Pharmacogenomics| PubMed ID: 17716234

2007
Germ-cell tumors.

The New England journal of medicine| PubMed ID: 17960020

2007
2007
HIV-associated Kaposi sarcoma and gender.

Gender medicine| PubMed ID: 18022592

2007
2007
2007
Cardiotoxicity and anthracyclines.

Breast cancer research and treatment| PubMed ID: 18167621

2008
The risks and incidence of K65R and L74V mutations and subsequent virologic responses.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America| PubMed ID: 18171220

2008
2008
HIV-associated multicentric Castleman's disease.

American journal of hematology| PubMed ID: 18260115

2008
2008
2008
2008
Use of antidepressants and risk of cancer in individuals infected with HIV.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 18467722

2008
2009
Bendamustine as a model for the activity of alkylating agents.

Future oncology (London, England)| PubMed ID: 18518757

2008
HIV, hepatitis B and hepatitis C coinfection in Kenya.

AIDS (London, England)| PubMed ID: 18525268

2008
2008
2008
FLEX data, KRAS and ERCC1 testing in oncology.

Future oncology (London, England)| PubMed ID: 18684058

2008
Host pharmacogenetics in the treatment of HIV and cancer.

Current drug safety| PubMed ID: 18690920

2006
Progression-free versus overall survival and adequate powering in randomised studies.

European journal of cancer (Oxford, England : 1990)| PubMed ID: 18790634

2008
2008
2008
2008
Why does cytotoxic chemotherapy cure only some cancers?

Nature clinical practice. Oncology| PubMed ID: 18982000

2009
2008
FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's disease.

European journal of nuclear medicine and molecular imaging| PubMed ID: 19050873

2009
2008
Thyroid dysfunction and relationship to antiretroviral therapy in HIV-positive individuals in the HAART era.

Journal of acquired immune deficiency syndromes (1999)| PubMed ID: 19092451

2009
2009
Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 19114688

2009
The efficacy of percutaneous vertebroplasty for vertebral metastases associated with solid malignancies.

European journal of cancer (Oxford, England : 1990)| PubMed ID: 19223174

2009
2009
Positioning pemetrexed in the treatment of ovarian cancer.

European journal of cancer (Oxford, England : 1990)| PubMed ID: 19264477

2009
HIV-1 step study.

Lancet| PubMed ID: 19269507

2009
The relationship between prolonged antiretroviral therapy and cryptogenic liver disease.

Journal of acquired immune deficiency syndromes (1999)| PubMed ID: 19300102

2009
2009
Epstein-Barr virus in Burkitt's lymphoma: the missing link.

The Lancet. Oncology| PubMed ID: 19341975

2009
2009
Receptor-based predictors of response in breast cancer.

Future oncology (London, England)| PubMed ID: 19374534

2009
Not so SMART?

The Lancet. Infectious diseases| PubMed ID: 19393954

2009
2009
Peritoneal disease in breast cancer: a specific entity with an extremely poor prognosis.

European journal of cancer (Oxford, England : 1990)| PubMed ID: 19464163

2009
A multicentre cohort experience with double-boosted protease inhibitors.

The Journal of antimicrobial chemotherapy| PubMed ID: 19474068

2009
2009
Non-AIDS-defining cancers.

Current opinion in infectious diseases| PubMed ID: 19532075

2009
Trastuzumab: unusual responses and toxicities.

Future oncology (London, England)| PubMed ID: 19663728

2009
Epigenetic modifications in AML and MDS.

Leukemia research| PubMed ID: 19665226

2010
The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 19706389

2009
[11C]choline positron emission tomography in estrogen receptor-positive breast cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 19706823

2009
ELISPOT and functional T cell analyses using HLA mono-specific target cells.

Journal of immunological methods| PubMed ID: 19729014

2009
2010
A meta-analysis of transient elastography for the detection of hepatic fibrosis.

Journal of clinical gastroenterology| PubMed ID: 19745758

2010
Bevacizumab and surgery: what is the real risk?

Future oncology (London, England)| PubMed ID: 19792957

2009
Circulating tumour cells as more than prognostic markers.

The Lancet. Oncology| PubMed ID: 19836306

2009
2009
Altered tissue 3'-deoxy-3'-[18F]fluorothymidine pharmacokinetics in human breast cancer following capecitabine treatment detected by positron emission tomography.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 19861447

2009
Serum molecular signatures of weight change during early breast cancer chemotherapy.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 19861449

2009
Unique localization of circulating tumor cells in patients with hepatic metastases.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 19884529

2009
2009
2010
2010
2010
Kinases as targets in the treatment of solid tumors.

Cellular signalling| PubMed ID: 20096351

2010
2010
2010
A single-center cohort experience of raltegravir in salvage patients failing therapy.

Journal of acquired immune deficiency syndromes (1999)| PubMed ID: 20335744

2010
PARP inhibitors in BRCA1-/BRCA2-associated and triple-negative breast cancers.

Future oncology (London, England)| PubMed ID: 20373860

2010
2010
2010
Clinical significance of circulating tumor cells.

Biomarkers in medicine| PubMed ID: 20477376

2007
2010
2010
2010
Cytokine and adhesion molecule expression evolves between the neutrophilic and lymphocytic phases of viral meningitis.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research| PubMed ID: 20626298

2010
Reproducibility of [11C]choline-positron emission tomography and effect of trastuzumab.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 20682702

2010
Combining luteinising hormone releasing hormone agonists and aromatase inhibitors in breast cancer.

European journal of cancer (Oxford, England : 1990)| PubMed ID: 20880696

2010
2011
2010
The anti-tumor effects of human immunodeficiency virus protease inhibitors: ready for real time?

International journal of cancer. Journal international du cancer| PubMed ID: 20981781

2011
2010
2008
2011
The evolution of coreceptor tropism in HIV-infected patients interrupting suppressive antiretroviral therapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America| PubMed ID: 21292672

2011
2011
2011
Combination antiretroviral therapy toxicities: a comparison between patients and health care professionals.

Journal of acquired immune deficiency syndromes (1999)| PubMed ID: 21350362

2011
Breast cancer (metastatic).

BMJ clinical evidence| PubMed ID: 21418674

2010
2011
The pharmacoeconomics of spiralling cancer drug costs - is there a viable solution?

European journal of cancer (Oxford, England : 1990)| PubMed ID: 21550231

2011
Outcomes in unresectable and locally advanced resected cholangiocarcinoma.

Expert review of anticancer therapy| PubMed ID: 21554045

2011
Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 21555697

2011
The HVTN 503/Phambili study: efficacy is always the issue.

The Lancet. Infectious diseases| PubMed ID: 21570356

2011
2011
2011
Breast Cancer in the Setting of HIV.

Pathology research international| PubMed ID: 21660281

2011
2012
2011
Breast cancer (non-metastatic).

BMJ clinical evidence| PubMed ID: 21718560

2011
Colorectal cancer in HIV positive individuals: the immunological effects of treatment.

European journal of cancer (Oxford, England : 1990)| PubMed ID: 21778048

2011
AIDS-Related Pathology.

Pathology research international| PubMed ID: 21845208

2011
2011
2011
2011
2011
Antioxidants and cancer.

The Lancet. Oncology| PubMed ID: 21968225

2011
2012
[18F]-3'Deoxy-3'-fluorothymidine positron emission tomography and breast cancer response to docetaxel.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 22028493

2011
2011
Shark cartilage: has the popularisation of science failed?

The Lancet. Oncology| PubMed ID: 22225719

2012
Improving outcomes in cholangiocarcinomas.

Gastrointestinal cancer research : GCR| PubMed ID: 22295130

2011
The role of pseudokinases in cancer.

Cellular signalling| PubMed ID: 22330072

2012
Cell-free DNA as a biomarker in the context of cancer, viruses, and methylation.

The Journal of infectious diseases| PubMed ID: 22357695

2012
2012
Ginger: the root of cancer therapy?

The Lancet. Oncology| PubMed ID: 22381932

2012
2012
Whole blood stem cell re-infusion and escalated dose melphalan in castration-resistant prostate cancer: a phase 1 study.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 22392912

2012
2012
An overview of drug development for metastatic breast cancer.

British journal of nursing (Mark Allen Publishing)| PubMed ID: 22470903

2012
2012
2012
2012
2012
miRNAs in breast cancer: ready for real time?

Pharmacogenomics| PubMed ID: 22515613

2012
Coffee: the science and art of moderation.

The Lancet. Oncology| PubMed ID: 22554541

2012
2012
2012
Retinoblastoma protein determines aggressiveness in triple-negative breast cancer.

Expert review of anticancer therapy| PubMed ID: 22594893

2012
The emerging harm of antioxidants in carcinogenesis.

Future oncology (London, England)| PubMed ID: 22646769

2012
2012
2012
2012
Raising a glass of red wine against cancer, or not?

The Lancet. Oncology| PubMed ID: 22748257

2012
2012
Loss of miR-126 is crucial to pancreatic cancer progression.

Expert review of anticancer therapy| PubMed ID: 22845403

2012
2012
Ayurveda: alternative or complementary?

The Lancet. Oncology| PubMed ID: 22935233

2012
Hide and seek: tell-tale signs of breast cancer lurking in the blood.

Cancer metastasis reviews| PubMed ID: 23108389

2013
Role of miRNAs in the response to anticancer therapy.

Pharmacogenomics| PubMed ID: 23171328

2012
2012
2012
Towards a clinical use of miRNAs in pancreatic cancer biopsies.

Expert review of molecular diagnostics| PubMed ID: 23256701

2013
LATS2 is a modulator of estrogen receptor alpha.

Anticancer research| PubMed ID: 23267128

2013
Aristolochia: the malignant truth.

The Lancet. Oncology| PubMed ID: 23276364

2013
MicroRNAs in the cancer clinic.

Frontiers in bioscience (Elite edition)| PubMed ID: 23276982

2013
2013
2013
Ginseng: panacea among herbal remedies?

The Lancet. Oncology| PubMed ID: 23452355

2013
2013
2013
2013
Chocolate: delicious beauty or harmful beast?

The Lancet. Oncology| PubMed ID: 23639314

2013
2013
Cancer stem cells--therapeutic targeting or therapy?

The Lancet. Oncology| PubMed ID: 23725700

2013
2013
The dual function of KSR1: a pseudokinase and beyond.

Biochemical Society transactions| PubMed ID: 23863182

2013
2013
2013
2013
2013
Milk thistle: early seeds of potential.

The Lancet. Oncology| PubMed ID: 23993379

2013
2013
2014
2013
Nuts and cancer: where are we now?

The Lancet. Oncology| PubMed ID: 24176559

2013
2013
Mistletoe: for cancer or just for Christmas?

The Lancet. Oncology| PubMed ID: 24275128

2013
2013
2013
Broader implications of a stage-guided stratified therapeutic approach for AIDS-related Kaposi's sarcoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 24378412

2014
2014
A microRNA meta-signature for pancreatic ductal adenocarcinoma.

Expert review of molecular diagnostics| PubMed ID: 24575833

2014
2014
Crystals and cancer: good vibrations or bad intentions?

The Lancet. Oncology| PubMed ID: 24599925

2014
2014
2014
2014
2014
2014
2014
Hyperthermia in cancer: is it coming of age?

The Lancet. Oncology| PubMed ID: 24807858

2014
2014
Cancer: Where were we, where are we, where are we going.

The Medico-legal journal| PubMed ID: 24913229

2014
2014
2014
Reply to S.E. Krown et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 25002718

2014
Exploiting interleukin 6 in multicentric Castleman's disease.

The Lancet. Oncology| PubMed ID: 25042200

2014
2014
Electrotherapy: enlightening modern medicine.

The Lancet. Oncology| PubMed ID: 25186041

2014
Circulating free DNA in the management of breast cancer.

Annals of translational medicine| PubMed ID: 25332979

2014
2014
Uncaria tomentosa, the cat's whiskers or claws?

The Lancet. Oncology| PubMed ID: 25439687

2014
2015
2014
2014
Black cohosh, hot flushes, and breast cancer.

The Lancet. Oncology| PubMed ID: 25638678

2015
2015
2015
2015